Services on Demand
- Cited by SciELO
- Access statistics
Print version ISSN 0034-7094On-line version ISSN 1806-907X
Rev. Bras. Anestesiol. vol.56 no.1 Campinas Jan./Feb. 2006
Intravenous dexmedetomidine for sedation does not interfere with sensory and motor block duration during spinal anesthesia*
La dexmedetomidina para sedación, por vía venosa, no interfiere con la duración del bloqueo sensitivo y motor de la raquianestesia
Edno Magalhães, TSAI; Luís Cláudio de Araújo Ladeira, TSAII; Cátia Sousa Govêia, TSAII; Beatriz Vieira EspíndolaIII
IProfessor Adjunto da Área de
Clínica Cirúrgica da Faculdade de Medicina da Universidade de Brasília
(UnB); Responsável pelo CET da Clínica de Anestesiologia da Universidade
IIMédico Assistente da Clínica de Anestesiologia do Hospital Universitário de Brasília, Universidade de Brasília (UnB); Co-responsável pelo CET da Clínica de Anestesiologia da Universidade de Brasília
IIIMédica Assistente da Clínica de Anestesiologia do Hospital Universitário de Brasília, Universidade de Brasília (UnB)
BACKGROUND AND OBJECTIVES: The association among local and regional anesthesia
is a very useful and common practice. However, some patients may become
anxious and require sedation. Benzodiazepines, opioids and propofol are
widely used for this aim. Alpha2-adrenergic agonists have hypnotic and
sedative properties and represent an alternative to promote hemodynamic
stability and minor respiratory depression. This study aimed at evaluating
the safety and the interference of intravenous dexmedetomidine or midazolam
on sensory and motor block duration spinal anesthesia.
METHODS: Thirty five adult female patients, physical status ASA I and II, were submitted to spinal anesthesia with hyperbaric 0.5% bupivacaine (15 mg) for elective gynecologic surgery. The patients were randomized and distributed in two groups: Group M (n = 17) - sedation with 0.25 µg.kg-1.min-1 midazolam continuous infusion and Group D (n = 18) sedation with 0.5 µg.kg-1.min-1 dexmedetomidine continuous infusion. Infusion rate was adjusted to maintain BIS between 60 and 80. The following parameters were evaluated: SBP, DBP, HR, SpO2, BIS sensory and motor block extension and duration (Bromage scale).
RESULTS: There were no statistically significant differences between groups in age, weight, sensory block level, blood pressure and heart rate variation and sensory and motor block duration.
CONCLUSIONS: Intravenous dexmedetomidine for sedation has not interfered with hemodynamic parameters, spinal anesthesia sensory and motor block duration or extension and it is a good option for sedation during local/regional anesthesia.
Key Words: ANALGESICS: dexmedetomidine; ANESTHETICS, Local: hyperbaric bupivacaine; ANESTHETIC TECHNIQUES, Regional: spinal block
JUSTIFICATIVA Y OBJETIVOS: La anestesia
regional se practica con frecuencia en anestesiología. No obstante, algunos
pacientes pueden mostrar ansiedad, necesitando en ese caso sedación. Los
benzodiazepínicos, opioides y propofol son ampliamente utilizados para
este propósito. Los agonistas alfa 2-adrenérgicos tienen propiedades
hipnóticas y sedativas y son una alternativa terapéutica por la estabilidad
hemodinámica y mínima depresión respiratoria. El objetivo de
este estudio es evaluar la seguridad e interacciones de dexmedetomidina y midazolam
por vía intravenosa en la duración del bloqueo sensitivo y motor de
MÉTODO: Fueron estudiadas 35 pacientes adultas, estado físico ASA I y II, que recibieron raquianestesia con bupivacaína a 0,5% hiperbárica (15 mg), para cirugía ginecológica electiva, distribuidas de modo aleatorio en 2 grupos: grupo M (n = 17) - sedación con midazolam en infusión continua a 0,25 µg.kg-1.min-1 y grupo D (n = 18) - sedación con dexmedetomidina en infusión continua a 0,5 µg.kg-1.min-1. La velocidad de infusión fue ajustada para mantener el valor del BIS entre 60 y 80. Fueron analizados los valores de PAS, PAD, FC, SpO2, BIS, extensión y duración del bloqueo sensitivo motor (escala de Bromage).
RESULTADOS: No hubo diferencia estadística entre los grupos en edad, peso, nivel de bloqueo sensitivo y duración bloqueo sensitivo motor, como de la frecuencia cardíaca y presión arterial.
CONCLUSIONES: La dexmedetomidina utilizada en sedación, por vía venosa, no alteró los parámetros hemodinámicos, duración o extensión de los bloqueos sensitivo y motor de la raquianestesia, representando una buena opción para sedación durante anestesia regional.
The combined local/regional anesthesia is widely accepted as an effective method for modern anesthetic practice. This technique allows the control of endocrine and metabolic response to trauma, decreases intraoperative blood loss and the incidence of postoperative thromboembolism, and promotes postoperative analgesia1.
Regional anesthesia, however, may promote some type of discomfort caused by the procedure itself or by a prolonged perioperative period, requiring the simultaneous administration of hypnotic, sedative and amnesic drugs. Benzodiazepines, propofol and opioids have these properties and provide some comfort to patients. However, they affect the ventilatory regulatory mechanisms and may lead to respiratory depression, with consequent hypercarbia and hypoxemia.
A promising alternative to these drugs in Anesthesiology is the group of alpha2-adrenergic agonists, which have excellent sedative and analgesic properties without respiratory depression. Dexmedetomidine is an alpha2-agonist with strong selectivity to the specific receptor and has been used as preanesthetic medication, as adjuvant to general anesthesia, as sedative during trans and postoperative period2-4.
Dexmedetomidine associated to local/regional anesthesia would provide a synergistic pharmacological interaction prolonging the action of local anesthetics, improving hemodynamic stability, sedation and analgesia and not causing respiratory depression2,4.
This study aimed at comparing physiological parameters of intravenous sedation with midazolam and dexmedetomidine and at evaluating the influence of dexmedetomidine in doses clinically indicated for sedation, on the duration of sensory and motor block promoted by spinal hyperbaric bupivacaine.
After the Research Ethics Committee, Universidade de Brasília approval and their informed consent, participated in this study 35 adult female patients, physical status ASA I and II, submitted to spinal anesthesia and intravenous sedation with dexmedetomidine or midazolam continuous infusion for elective gynecologic procedures. Exclusion criteria were patients with known renal, liver or heart function disorders, morbidly obese, under anti-hypertensive medication or counterindicated to regional anesthesia.
Patients were premedicated with diazepam (10 mg) the day before and in the morning of the surgery day. Monitoring consisted of continuous ECG, noninvasive blood pressure (NIBP), oxygen peripheral saturation (SpO2) and EEG analysis by bispectral index (BIS).
Patients were randomly distributed in two groups. Group M (n = 17) - sedation with midazolam - intravenous midazolam continuous infusion at initial rate of 0.25 µg.kg-1.min-1 adjusted according to BIS (values maintained between 60 and 80). Group D (n = 18) - sedation with dexmedetomidine - intravenous dexmedetomidine continuous infusion at initial infusion rate of 0.5 µg.kg-1.min-1, adjusted according to BIS (values maintained between 60 and 80). Infusion regimen was adjusted in both groups to limit hypnosis to mild or superficial characterizing sedation (BIS between 60 and 80).
Considering the easily identified difference between infusion rates for dexmedetomidine and midazolam aiming at the same BIS level, this study was not blind.
After venous puncture and monitoring, spinal anesthesia was induced with disposable 25G Quincke needle and hyperbaric 0.5% bupivacaine (15 mg). With patients in the supine position sensory block level started to be investigated (tactile sensitivity) one minute after spinal puncture and then at 5-minute intervals. Motor block intensity (Bromage) was initially evaluated until total motor block installation and then at surgery completion at 10-minute intervals for blockade regression. Midazolam or dexmedetomidine infusion was started 10 minutes after anesthetic induction.
Systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), BIS, sensory level and motor block intensity were evaluated every 5 minutes in the perioperative period. At surgery completion patients were referred to the post-anesthetic recovery unit (PACU) and were observed to check motor and sensory block duration. Motor block duration was considered time elapsed before patients were able to bend the knee and raise the stretched leg (no motor block according to Bromage scale).
Students t test was used for statistical analysis considering significant p < 0.05.
Demographics data (Table I) were not statistically different between groups. All patients had total motor block (impossibility of bending feet - Bromage) and sensory block level mode was T4 (Table II) for both groups. Hemodynamic variables - systolic blood pressure, diastolic blood pressure and heart rate (Figure 1, Figure 2 and Figure 3) - were not statistically different between groups in studied moments. Time for total motor block regression according to Bromage scale (Figure 4) was 249.7 ± 31.8 min for group D and 240.6 ± 39.2 min for group M, without statistically significant difference (p = 0.455) (Table III). Time for total sensory block regression was 219.7 ± 25.4 min for group D and 197.5 ± 40.9 min fir group M, without statistically significant difference (p = 0.062).
Alpha2-adrenergic receptor agonists are beneficial for anesthesia. They provide hemodynamic stability and sedation, decrease the need for anesthetics and analgesics5, and have no marked depressing effects on ventilation. Their action mechanism is not related to neurotransmitters synthesis, storage or metabolism and is reversible with vasoactive agents, agonists of these receptors, or by withdrawing the drug6,7. Dexmedetomidine is more selective to alpha2-adrenergic receptors as compared to clonidine. Dexmedetomidine has fast onset and short half-life promoting decreased norepinephrine plasma levels, hemodynamic stability, sedation and analgesia without respiratory depression8.
Some proposed mechanisms for the action of alpha2-adrenergic agonists combined to local anesthetics include vasoconstriction, facilitation of C fibers blockade by local anesthetics, interference on retrograde axonal transportation at medullary level and action on peripheral nerve receptors9. Some reports discuss longer sensory and motor block duration induced by alpha2-adrenergic agonists during neuraxial blocks9.
Rhee et al. have observed increased sensory and motor block duration induced by intravenous clonidine associated to spinal anesthesia10. Memis et al. have observed faster motor block installation and slower recovery of total motor activity when dexmedetomidine was associated to intravenous regional anesthesia with lidocaine11. The interference of alpha2-adrenergic agents on motor activity was not the objective of the above-mentioned studies. Studies aiming at determining the actual interference of such drug on motor and sensory block duration are needed and should be reproduced.
Single or repeated dose in anesthesia could be an inadequate alternative to measure the effects of a drug. Hu et al., using mathematical simulations, have forecasted twice the variation coefficient in plasma concentration of a drug in bolus as compared to continuous infusion12. This may promote high plasma concentrations of drugs and the presence of adverse effects. Continuous infusion allows the maintenance of constant plasma concentration of drugs, preventing decreased effects and the possibility of adverse reactions.
Systemic single dose as opposed to continuous infusion may be responsible for unexpected motor block duration increase. Sudo et al. have found this characteristic in an animal study where high systemic dexmedetomidine doses have increased motor block duration in animals submitted to spinal anesthesia with levobupivacaine, which was partially decreased by ioimbine13. Our study has not shown differences between dexmedetomidine or midazolam continuous infusion, in doses limited to promote sedation, with regard to sensory and motor block duration promoted by spinal anesthesia with hyperbaric 0.5% bupivacaine.
Dexmedetomidine for sedation has not changed blood pressure and heart rate values as compared to midazolam. It is possible that preanesthetic diazepam, a long half-life benzodiazepine may have influenced the level of perioperative sedation. However, both groups received the same preanesthetic medication and midazolam and dexmedetomidine infusion rates were adjusted for a target BIS value. So, we believe that decreased anesthetic need promoted by diazepam was similar for both groups. Our conclusion was that intravenous dexmedetomidine for sedation of patients submitted to spinal anesthesia is a good option for sedation, with hemodynamic stability, adequate hypnosis and without changing motor and sensory block duration.
01. Bernards CM - Epidural and Spinal Anesthesia, em: Barash PG, Cullen BF, Stoelting RK - Clinical Anesthesia, Philadelphia, Lippincott Williams & Wilkins, 2001;689-713. [ Links ]
02. Aantaa R, Kallio A, Virtanen R - Dexmedetomidine, a novel a2-adrenergic agonist. A review of its pharmacodynamic characteristics. Drugs of the Future, 1993;18:49-56. [ Links ]
03. Erkola O, Korttila K, Aho M et al - Comparison of intramuscular dexmedetomidine and midazolam premedication for elective abdominal hysterectomy. Anesth Analg, 1994;79:646-653. [ Links ]
04. Hall JE, Uhrich TD, Barney JA et al - Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg, 2000;90:699-705. [ Links ]
05. Magalhães E, Goveia CS, Ladeira LCA et al - Relação entre a infusão contínua de dexmedetomidina e a fração expirada de sevoflurano monitorizada pelo índice bispectral. Rev Bras Anestesiol, 2004;54:303-310. [ Links ]
06. Aantaa R, Scheinin M - Alpha2-adrenergic agents in anaesthesia. Acta Anaesthesiol Scand, 1993;37:433-48. [ Links ]
07. Hayashi Y, Maze M - Alpha2-adrenoceptor agonists and anaesthesia. Br J Anaesth, 1993;71:108-118. [ Links ]
08. Alves TCA, Braz JRC, Vianna PTG - Alfa2-agonistas em Anestesiologia: aspectos clínicos e farmacológicos. Rev Bras Anestesiol, 2000;50:396-404. [ Links ]
09. Gabriel JS, Gordin V - Alpha 2 agonists in regional anesthesia and analgesia. Curr Opin Anaesthesiol, 2001;14:751-753. [ Links ]
10. Rhee K, Kang K, Kim J et al - Intravenous clonidine prolongs bupivacaine spinal anesthesia. Acta Anaesthesiol Scand, 2003;47:1001-1005. [ Links ]
11. Memis D, Turan A, Karamanlioglu B et al - Adding dexmedetomidine to lidocaine for intravenous regional anesthesia. Anesth Analg, 2004;98:835-40. [ Links ]
12. Hu C, Horstman DJ, Shafer SL - Variability of target-controlled infusion is less than the variability after bolus injection. Anesthesiology, 2005;102:639-645. [ Links ]
13. Sudo RT, Calasans-Maia JA, Zapata-Sudo G - Systemic administration of dexmedetomidine increased the duration of spinal anesthesia induced by levobupivacaine. Anesthesiology, 2003;99:A955. [ Links ]
Dr. Edno Magalhães
Address: SOS 113, Bloco C/Aptº 406
ZIP: 70376-030 City: Brasília, Brazil
Submitted for publication July 4, 2005
Accepted for publication October 10, 2005
* Received from Hospital Universitário de Brasília, Universidade de Brasília, Brasília, DF